Back to results
RecruitingPhase 1

Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors

NCT06337084

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Melbourne Theranostic Innovation Centre (MTIC)

North Melbourne, Victoria, Australia

Contact

Director Clinical Operations

847-794-8435monitoring@monopartx.com
View on ClinicalTrials.gov
Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors — TrialFind